” A few years from now, we will probably be looking at 2023 as the beginning of a new era in cancer treatment. “Nicolas Poirier, CEO, OSE Immunotherapeutics, with flavor” the runaway ” of which his company is the subject, with positive results for a lung cancer vaccine.
Its findings also shine a spotlight on a nascent market that is already sparking competition among pharmaceutical industry players. It took several months to change the situation. Last May, Germany’s BioNTech, which made a name for itself with its RNA vaccine against Covid, along with Pfizer, announced promising results from a vaccine trial with Switzerland’s Roche that targets pancreatic cancer. In December 2022, Moderna announced positive results from a Phase 2 trial against melanoma. Two biotechs that have built their success around messenger RNA technology have caused cancer since their inception…
Source: Le Figaro
I am John Sinkler, a professional writer and journalist for Buna Times. I specialize in writing about entertainment-related topics and have been doing so for several years now. My work has been featured on multiple platforms and I’m proud to say that it’s gained recognition from many people in the industry. Aside from working at Buna Times, I also write freelance articles for other publications.